Previous 10 | Next 10 |
My Roth IRA portfolio of 29 CEFs and 29 REITs for income, and 124 stocks for swing trading mostly under-performing S&P 500 stocks, continues to realize profits. In June, I closed 6 stock trades for a net gain, including dividends, of 43.33% (median) or 50.47% (cost-weighted), for ...
Organon (NYSE: OGN) has been notified of an unsolicited mini-tender offer by TRC Capital Investment Corporation (“TRC”) to purchase up to 3,000,000 shares of Organon common stock from Organon stockholders, representing approximately 1.18% of the outstanding shares of Organ...
putilich/iStock via Getty Images Organon (OGN) and Merck (MRK) have dropped a case against Microspherix that sought a covenant not to sue from Microspherix. Microspherix and Merck have been embroiled for years in legal proceedings over Merck's (and now Organon's) birth control implant Nexplan...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It doesn’t make sense, really. Organon (NYSE: OGN ) was recently spun off from pharmaceutical giant Merck (NYSE: MRK ), so you’d think Wall Street would be buzzing about OGN stock. So...
In its first earnings report as a separately traded company from Merck (MRK), Organon (OGN) reiterated a forecast made in early May that its sees full year 2021 revenue of between $6.1B and $6.4B.The company also sees adjusted EBITDA margin in a range of 36% to 38%.The revenue forecast, howev...
Organon (OGN): Q1 GAAP EPS of $1.58.Revenue of $1.51B (-15.2% Y/Y)Shares +0.73% PM.Press Release For further details see: Organon reports Q1 results
Company affirms guidance provided during May 3 rd Investor Day; will host second quarter earnings call on or about August 12, 2021 Organon (NYSE: OGN) (the “company”), today announced that it has filed a Form 10-Q for the quarter ended March 31, 2021. In th...
Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal morbidity and mortality caused by postpartum hemorrhage (PPH) or abnormal postpar...
The market is trading at some of the most overvalued levels in 20 years. Over the next five years, analysts expect 5% CAGR returns from the S&P 500. That's about 1/3 of what investors have enjoyed for the last decade. But it's a market of stocks, not a stock market, and incredible...
Healthcare sector and Real Estate Select Sector SPDR ETF (XLRE) gain of 1.92% and 1.88% respectively during the week outpaced S&P 500 gain of +0.40%.Looking at larger stocks (over $2B market capitalization), far and away the sector's top gainer was "meme stock" favorite ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...
2024-06-08 06:50:00 ET Not all dividend stocks are equal. Some are safer than others. Some have much higher dividend yields than others. When a stock offers both advantages, it's usually a keeper. Three Motley Fool contributors have found stocks with mouthwatering dividends that you...